Safety and Effect of Elbasvir/Grazoprevir Combination Therapy in Hemodialysis Patients With Chronic Hepatitis C
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03022006|
Recruitment Status : Unknown
Verified April 2017 by Goki Suda, Norte Study Group.
Recruitment status was: Recruiting
First Posted : January 16, 2017
Last Update Posted : April 12, 2017
Norte Study Group
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Goki Suda, Norte Study Group
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||March 2019|
|Study Completion Date :||No date given|